ПЛАКОГИАННИС Фотиос М. (US),ХОССЭЙН Мухаммед Анвар (US)
申请号：
RU2013124401/15
公开号：
RU2013124401A
申请日:
2011.10.20
申请国别(地区):
RU
年份:
2014
代理人:
摘要：
1. A pharmaceutical composition comprising aripiprazole in a dosage form for transdermal dostavki.2. A pharmaceutical composition according to Claim. 1, wherein the aripiprazole is in liquid or gel forme.3. A pharmaceutical composition according to Claim. 1, wherein the aripiprazole is present in an amount of 1 to 20 wt.% / Ob.4. A pharmaceutical composition according to claim. 2, wherein the aripiprazole is present in an amount of 1 to 20 wt.% / Ob.5. A pharmaceutical composition according to claim. 2, wherein the gel comprises a gelling agent in the range of about 0.1 to 5 wt.% / Ob.6. A pharmaceutical composition according to Claim. 1 further comprising about 40% N-methyl-2-pyrrolidone, 40% DMSO, 15% alcohol and 5% vody.7. A pharmaceutical composition according to Claim. 1, which is in liquid form and comprising an alcohol, glycol, mineral oil and / or vegetable maslo.8. A pharmaceutical composition according to claim. 2, wherein the composition is in the form of a gel and further comprises a gelling agent selected from the group consisting of natural polymers, semisynthetic polymers, synthetic polymers, carboxyvinyl polymers or carbomers, Carbopol 940, Carbopol 934, Carbopol 971, poloxamer, polyacrylamide, polyvinyl alcohol, polyethylene and its sopolimerov.9. A pharmaceutical composition according to Claim. 1, where the shape is a patch for transdermal dostavki.10. A pharmaceutical composition according to Claim. 1, which is present in the dosage form of ointments, lotions, emulsions or liposomy.11. The pharmaceutical composition of claim. 10 wherein aripiprazole is present in an amount of 1 to 20 wt.% / Ob.12. A pharmaceutical composition according to Claim. 1 further comprising usilitel.13. Pharmaceutical1. Фармацевтическая композиция, содержащая арипипразол в лекарственной форме для трансдермальной доставки.2. Фармацевтическая композиция по п. 1, в которой арипипразол находится в гелеобразной или жидкой форме.3. Фармацевтическая композиция по п. 1, в которой
